Evidence map›Paper›PMID 30737492›Full record

ReviewNature reviews. Genetics2019

Induced pluripotent stem cells in disease modelling and drug discovery.

R Grant Rowe, George Q Daley

Registry-linked trialAbstract readReview
In one paragraph

Review in Nature reviews. Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05892822 (Amyotrophic Lateral Sclerosis Registry), which is not on this map. Cited by 369 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
369citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05892822 unknown statusnot on this mapstarted 2023, after this paper: background citation

Amyotrophic Lateral Sclerosis Registry

Typeobservational_patient_registrySponsoryilong WangRan2023 to 2024Enrolled1,000ConditionsAmyotrophic Lateral SclerosisArmsAmyotrophic Lateral Sclerosis
3 · Its place in the literature

Who cites it

369 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

309 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

R Grant RoweBoston Children's Hospital and Harvard Medical School, Boston, MA, USA.
George Q DaleyBoston Children's Hospital and Harvard Medical School, Boston, MA, USA. george_daley@hms.harvard.edu.ORCID http://orcid.org/0000-0002-6346-5919

Funding

Role of the Lin28b/let-7 axis in the maturation of hematopoietic progenitor cellsK08DK114527 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ROWE, ROBERT GRANT · 2017 to 2021
$704k
NIDDK NIH HHS K08 DK114527
6 · The paper itself

Abstract

The derivation of induced pluripotent stem cells (iPSCs) over a decade ago sparked widespread enthusiasm for the development of new models of human disease, enhanced platforms for drug discovery and more widespread use of autologous cell-based therapy. Early studies using directed differentiation of iPSCs frequently uncovered cell-level phenotypes in monogenic diseases, but translation to tissue-level and organ-level diseases has required development of more complex, 3D, multicellular systems. Organoids and human-rodent chimaeras more accurately mirror the diverse cellular ecosystems of complex tissues and are being applied to iPSC disease models to recapitulate the pathobiology of a broad spectrum of human maladies, including infectious diseases, genetic disorders and cancer.

Indexed as

Models, BiologicalAnimalsCell DifferentiationCell LineageChimeraCommunicable DiseasesDrug DiscoveryGenetic Diseases, InbornGenetic TherapyHumansInduced Pluripotent Stem CellsModels, AnimalNeoplasmsOrganoidsTissue EngineeringTissue Transplantation

Identifiers

PMID30737492
PMCPMC6584039

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.